iHuman Institute, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai 201210, China.
The National Center for Drug Screening and the CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China.
Nature. 2017 Jun 8;546(7657):312-315. doi: 10.1038/nature22378. Epub 2017 May 17.
The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis. The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner. Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 Å resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.
胰高血糖素样肽-1 受体(GLP-1R)和胰高血糖素受体(GCGR)是分泌素样 B 类 G 蛋白偶联受体(GPCR)家族的成员,在胰岛素释放和葡萄糖稳态方面具有相反的生理作用。2 型糖尿病的治疗需要正向调节 GLP-1R,以抑制胰高血糖素分泌并以葡萄糖依赖的方式刺激胰岛素分泌。在这里,我们报告了人 GLP-1R 跨膜结构域与两种不同的负变构调节剂 PF-06372222 和 NNC0640 复合物的晶体结构,分辨率分别为 2.7 和 3.0 Å。这些结构揭示了一个共同的负变构调节剂结合口袋,存在于 GLP-1R 和 GCGR 中,位于受体细胞内半部分的 V-VII 螺旋附近。该受体处于无活性构象,化合物限制了螺旋 VI 细胞内尖端的运动,这种运动通常与 A 类 GPCR 中的激活机制相关。分子建模和突变研究表明,激动剂正变构调节剂以相同的一般区域为靶点,但在 V 和 VI 螺旋之间的界面上存在一个不同的亚口袋,这可能有助于形成增强 G 蛋白偶联的细胞内结合位点。